This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Leland Stanford Junior University. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: The Innovations of Leon Lih-Ren Su
Introduction
Leon Lih-Ren Su is an accomplished inventor based in Mountain View, California. He has made significant contributions to the field of biotechnology, particularly in the development of interleukin-2 muteins. His work has implications for the treatment of autoimmune diseases, showcasing the potential of his innovations in medical applications.
Latest Patents
Leon Lih-Ren Su holds a patent for "Partial agonists of interleukin-2." This patent provides human interleukin-2 (IL-2) muteins or variants that exhibit a decreased binding capacity for IL-2Rγ. These IL-2 muteins serve as partial agonists in applications where the reduction or inhibition of IL-2 and/or IL-15 functions is beneficial, such as in treating autoimmune diseases. The patent also includes nucleic acids encoding these IL-2 muteins, methods for their production, and pharmaceutical compositions that incorporate them.
Career Highlights
Leon Lih-Ren Su is affiliated with Leland Stanford Junior University, where he continues to advance his research and innovations. His work is characterized by a commitment to improving therapeutic strategies through innovative biotechnological solutions.
Collaborations
Some of his notable coworkers include Kenan Christopher Garcia and Sonia S Majri. Their collaborative efforts contribute to the ongoing research and development in the field of biotechnology.
Conclusion
Leon Lih-Ren Su's contributions to the field of biotechnology, particularly through his patent on interleukin-2 muteins, highlight his role as an innovative inventor. His work has the potential to significantly impact the treatment of autoimmune diseases and advance medical science.